Phathom Pharmaceuticals, Inc. — Director's Dealing 2021

Jul 14, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2021-07-13

Reporting Person: Parikh Asit (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-13	Stock Option (Right to Buy)	$34.05	A	7500	Acquired	2031-07-12	Common Stock (7500)	Direct

Footnotes

F1: The option was granted as compensation for services provided to the Registrant as a director. The option shall vest and/or become exercisable on the first anniversary of the date of grant subject to Reporting Person's continuing in service on the Board through such vesting date.